GE BIOTECH DIVISION TO DANAHER

GE to Sell Its Biotech Business to Danaher for $21 Billion – The Wall Street Journal.

GE attains some needed cash flow help as it prepares to spin off health care. One division, biotech, will not be part of the new company, but will find a new home in Danaher.

CEO Larry Culp Hope’s to restructure the iconic conglomerate in order to provide better returns and improve retained earnings.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s